Compare Ginkgo Bioworks Holdings Inc (DNA) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Lockheed Martin Corporation — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Lockheed Martin Corporation trades at $596.91 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 272.8× Ginkgo Bioworks Holdings Inc's market cap, and Lockheed Martin Corporation pays a 2.31% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | LMT | |
|---|---|---|
Market Cap | $505.73M | $137.96B |
Sector | Health | Industrials |
52-Week High | $16.14 | $676.70 |
52-Week Low | $5.48 | $431.56 |
Enterprise Value | $607.68M | $154.71B |
Dividend Yield | — | 2.31% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
